|1.||Sinha, Raghu: 5 articles (07/2009 - 07/2004)|
|2.||El-Bayoumy, Karam: 5 articles (01/2008 - 09/2003)|
|3.||Pinto, John T: 4 articles (08/2009 - 03/2006)|
|4.||Farina, Marcelo: 2 articles (08/2013 - 11/2004)|
|5.||Dashwood, Roderick H: 2 articles (08/2009 - 07/2009)|
|6.||Bisson, William H: 2 articles (08/2009 - 07/2009)|
|7.||Nian, Hui: 2 articles (08/2009 - 07/2009)|
|8.||El-Bayoumy, K: 2 articles (02/2004 - 05/2001)|
|9.||Reddy, B S: 2 articles (05/2001 - 01/2001)|
|10.||Rao, C V: 2 articles (05/2001 - 01/2001)|
02/01/2008 - "The role of organoselenium compounds as potent cancer chemopreventive and chemotherapeutic agents has been supported by epidemiological, preclinical and clinical studies. "
08/01/2010 - "Differential apoptotic response of human cancer cells to organoselenium compounds."
12/08/2005 - "Continuous efforts are going on to develop suitable organoselenium compounds, which can be used as cancer chemopreventive agents for human. "
11/01/1997 - "These inhibitory actions may, in part, account for the mechanisms responsible for cancer prevention by organoselenium compounds in laboratory animals."
07/13/2004 - "Collectively, the results described here, suggest that the molecular targets modulated by organoselenium compounds are highly useful indicators of success in clinical cancer chemoprevention trials."
|3.||Breast Neoplasms (Breast Cancer)
|4.||Prostatic Neoplasms (Prostate Cancer)
10/01/2010 - "In the present study, we synthesized a series of organoselenium compounds and evaluated their possible chemopreventive properties in human prostate cancer LNCaP cells. "
10/01/2010 - "Identification of organoselenium compounds that possess chemopreventive properties in human prostate cancer LNCaP cells."
01/01/2008 - "Effects of naturally occurring and synthetic organoselenium compounds on protein profiling in androgen responsive and androgen independent human prostate cancer cells."
04/01/2007 - "Depending on the structure, organoselenium compounds exhibit differential effects on growth, PSA secretion, oxidative stress and selective gene responses in human prostate cancer cells and suggest the potential of developing novel organoselenium compounds as chemopreventive agents in models of human prostate cancer."
07/01/2009 - "We tested the hypothesis that natural organoselenium compounds might be metabolized to HDAC inhibitors in human prostate cancer cells. "
|5.||Colonic Neoplasms (Colon Cancer)
05/01/1996 - "Evaluation of organoselenium compounds for potential chemopreventive properties in colon cancer."
08/01/2009 - "Alpha-keto acid metabolites of organoselenium compounds inhibit histone deacetylase activity in human colon cancer cells."
11/01/1999 - "Two new organoselenium compounds, 4-ethyl-4-hydroxy-2-p-tolyl-4H-5,6-dihydro-1,3-selenazine (TS-2) and 4-hydroxy-4-methyl-6-propyl-2-p-tolyl-4H-5,6-dihydro-1,3-selenazine++ + (TS-6) were investigated for their inhibitory effect on the growth of 8 human tumor cell lines, including stomach, lung, prostate and colon cancer cell lines, in vitro. "
04/02/1997 - "Chemoprevention of colon cancer by organoselenium compounds and impact of high- or low-fat diets."
08/01/2009 - "These studies confirm that in addition to targeting redox-sensitive signaling molecules, alpha-keto acid metabolites of organoselenium compounds alter HDAC activity and histone acetylation status in colon cancer cells, as recently observed in human prostate cancer cells."
|10.||selenocyanic acid (selenocyanate)
|2.||Fat-Restricted Diet (Diet, Fat Restricted)